Navigation Links
CorNova(R) Expands Management Team with Appointment of Robert Gallahue as Chief Financial Officer
Date:2/17/2009

Company Also Names Richard Sahagian as Senior Scientist

BURLINGTON, Mass., Feb. 17 /PRNewswire/ -- CorNova(R), Inc. today announced the expansion of its executive team with the appointment of Robert Gallahue as chief financial officer. The company also announced the addition of Richard Sahagian as senior scientist.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070206/CLTU213LOGO )

The appointments reflect the evolution of the company's endovascular product line, which includes the FiberHalo(TM) stent deployment and post-dilatation balloon catheter, the FiberHalo(TM) pre-dilatation balloon catheter and the advanced Valecor Platinum(TM) Coronary Stent System.

"We needed to put in place the financial expertise required to move CorNova(R) closer to becoming an advanced development and commercial organization," said S. Eric Ryan, M.D., CorNova(R)'s chief executive officer. "Bob's depth of financial experience and knowledge of the biomedical industry will be a significant contribution to the growth and maturation of the company."

Gallahue, 48, has more than 20 years of financial management experience with public and private biotechnology and medical technology companies at various stages of clinical and commercial development. He has also successfully participated in a variety of financial transactions, including initial public offerings, mergers, joint ventures, private placements and follow-on offerings at a number of healthcare companies, including Molecular Insight Pharmaceuticals, Keryx Biopharmaceuticals and LeukoSite. He holds an M.S.A. from Bentley College and a B.A. from Middlebury College.

Sahagian, 46, has more than 20 years of experience in medical device development and production. He will be responsible for production of the Val
'/>"/>

SOURCE CorNova, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Global Biopharmaceutical Leader in Peptide Research Expands Commitment in San Diego/U.S. With New R&D Facility and Ready-To-Market Prostate Cancer Treatment Degarelix
2. Diplomat Specialty Pharmacy Expands National Hemophilia & IVIG Program
3. Amgens Breakaway from Cancer Initiative Expands to Help Cancer Patients Access Broad Spectrum of Cancer Resources and Services
4. Yourway Transport Expands Biological Services
5. Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO)
6. Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Property Estate
7. Yourway Transport Expands
8. MDV Expands Team Pursuing Advances in Personalized Medicine
9. Voler Expands Medical Device Design Capabilities
10. deCODE Study Expands Clinical Utility of deCODE AF(TM) for Improving the Diagnosis of Atrial Fibrillation and Preventing Stroke
11. Avid Bioservices Expands Capabilities With Installation of Innovative Thermo Scientific HyClone Single-Use Bioreactor Systems

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...The New York investment bank KTA Capital,s client ... AU$6.7 mil convertible note private placement wit...ment was arranged by KTA Capital as Neuren,s exclu... New York (PRWEB) November 23, 2009 -- T...l, LLC ("KTA Capital") has announced tha...
(Date:11/24/2009)...,Ontario,Nov.24/PRNewswire-FirstCall/--DowAgroScie...landSeeds,adivisionofThompsonsLimitedofBlenheim,On...AgroSciences,currentseedsbusinessasthecompanyantic...dDowAgroSciencesHerbicideTolerantTraitTechnologyin...rfuture. ,, "Thisacquisitionbringstogethertwost...
(Date:11/24/2009)...Newswire-FirstCall/--Sigma-AldrichCorporation(Nasd...onTuesday,December1stat1:45PMGMTinLondon,7:45AMUS/...tovertheInternetavailableat http://inve s tor.s...t"icontoaccessthisfile. ,, AboutSigma-Aldrich...logycompany.Itschemicalandbiochemicalproductsandki...
(Date:11/24/2009)...November24/PRNewswire-FirstCall/--deCODE,genetics,...fits,"firstday"motionsbytheU.S.BankruptcyCourtfort...lastweekfiledavoluntarypetitionfor,reliefunderChap...ptcyCourt. , TheordersissuedbytheBankruptcyCo...uringtheChapter11proceedings.Inparticular,the,comp...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...als, Inc. (Nasdaq: ISIS ) announced today that it...(Ibis), has been awarded four new,government contr...tection,and identification of microbial threat age...ntracts are from the Department of Homeland Securi...d total up to approximately,$3.3 million and a fou...
...SE: EHP) announced today that it has completed the... for potential biodefense drugs, and are,about to ...over the coming,year. The National Institutes of ...logical and Nuclear Threats (MCART) programme lead...ion sickness following a nuclear terrorist,attack....
...:,BIOD) today announced that it will amend its Qua...d ended June 30, 2007 to correct the manner in whi...nsation expense arising from,stock options granted...any,s initial public offering. The amendment will ...olely non-cash in nature. On May 10, 2007, the Co...
Other Biology Technology:Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development 2Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development 3Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development 4EpiStem Successfully Complete First Year of Mucositis Tests for NIH Biodefence Programme 2EpiStem Successfully Complete First Year of Mucositis Tests for NIH Biodefence Programme 3Biodel to Amend June 30, 2007 10-Q to Correct Non-Cash Share-Based Compensation Expense 2Biodel to Amend June 30, 2007 10-Q to Correct Non-Cash Share-Based Compensation Expense 3
(Date:11/23/2009)...ence that the "synergistic" effect of early-life e...and indoor endotoxin causes more harm to developin... Environmental health scientists at the Universit...n that children exposed to both high levels of tra... early life are six times more likely to experienc...
(Date:11/23/2009)...plied mathematicians dissected the morphology of t...istic long leaf with a saddle-like arc midsection ...mple cause of the lily,s fan-like shapeelastic rel... growthwas revealed by using an equally simple tec...a postdoctoral student at Harvard,s School of Engi...
(Date:11/23/2009)...Society says that western lowland gorillas living ...he "mother lode" of more than 125,000 gorillas dis...ned by growing humans activity in the region. , ...ts adjacent to the southwest border of Lac Tl Comm...high densities of the great apes still exist in th...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2The cause behind the characteristic shape of a long leaf revealed 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Watchful waiting is a viable option for prostate cancer patients with low risk tumors 55761 1Watchful waiting is a viable option for prostate cancer patients with low risk tumors 55761 2Watchful waiting is a viable option for prostate cancer patients with low risk tumors 55761 3Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference 55759 1Family Circle Magazine Features AmLactin 28R 29 in Article on Managing Dry Skin Associated With Keratosis Pilaris 55757 1Family Circle Magazine Features AmLactin 28R 29 in Article on Managing Dry Skin Associated With Keratosis Pilaris 55757 2
...or bioengineered crops, sequencing the genome coul.... Once the sequence is complete, the baton is pass...ions. A draft sequence of the soybean genome is no...able soon. Taking the next step in a new study, Un... researchers have demonstrated the applicability o...
...entory" of sea and land animals around a group of ... biodiversity and has more species than the Galapa...monitor how they will respond to future environmen... of Biogeography , the team from British Antarctic...ey combed the land, sea and shores of the South Or...
...(Sweden) Permission has been granted to start the...or a remedy for ALS. ALS is an incurable, paralyzi...ns in every 100,000. The disease commonly affects ...lives − without warning. Researchers from VI...ibilities for the use of VEGF in the treatment of ...
Other Biology News:Tool helps identify gene function in soybeans 2First trial in patients with a potential treatment of the incurable ALS muscle disease 2First trial in patients with a potential treatment of the incurable ALS muscle disease 3
...DA-GT12 Genetic Analyzer is a revolutionary multi...ultiple applications in one instrument platform. I...data analysis in one step, thus significantly impr... of medium to high-throughput laboratories . Bene...
...otofor purification system, 100-120 V, is used for...se isoelectric focusing (IEF). The system includes...ng chambers, chassis, harvesting apparatus, coolin...lytes (pH 3-10), 60 ml syringe, colored protein sa...
...mmEdge Pen, a hydrophobic barrier pen for immunohi...ed for use with frozen or paraffin-embedded tissue... provides a heat-stable, water-repellent barrier t...e sections, prevents mixing of reagents when diffe...
NBT/BCIP Chromogen System (SIGNET) from Covance Research Products, Inc
Biology Products: